Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-007370
Filing Date
2024-09-24
Accepted
2024-09-24 16:28:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3326
  Complete submission text file 0001950047-24-007370.txt   4791
Mailing Address C/O ICAHN CAPITAL LP 767 FIFTH AVENUE, SUITE 4700 NEW YORK NY 10153
Business Address
Mulligan Richard (Reporting) CIK: 0001376247 (see all company filings)

Type: 144

Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Subject) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39941 | Film No.: 241320472
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)